Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease.
Feldman HH, Messer K, Qiu Y, Sabbagh M, Galasko D, Turner RS, Lopez O, Smith A, Durant J, Lupo JL, Revta C, Balasubramanian A, Kuehn-Wache K, Wassmann T, Schell-Mader S, Jacobs DM, Salmon DP, Léger G, DeMarco ML, Weber F; ADCS VIVA-MIND Study Group. Feldman HH, et al. Among authors: jacobs dm. J Alzheimers Dis. 2024;101(s1):S79-S93. doi: 10.3233/JAD-231126. J Alzheimers Dis. 2024. PMID: 39422941 Free PMC article.
Comparison of the telephone-Montreal Cognitive Assessment (T-MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease.
Chappelle SD, Gigliotti C, Léger GC, Peavy GM, Jacobs DM, Banks SJ, Little EA, Galasko D, Salmon DP. Chappelle SD, et al. Among authors: jacobs dm. Alzheimers Dement. 2023 Oct;19(10):4599-4608. doi: 10.1002/alz.13039. Epub 2023 Mar 20. Alzheimers Dement. 2023. PMID: 36939111 Free PMC article.
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).
Feldman HH, Luchsinger JA, Léger GC, Taylor C, Jacobs DM, Salmon DP, Edland SD, Messer K, Revta C, Flowers SA, Jones KS, Koulman A, Yarasheski KE, Verghese PB, Venkatesh V, Zetterberg H, Durant J, Lupo JL, Gibson GE; ADCS BenfoTeam Study Group. Feldman HH, et al. Among authors: jacobs dm. PLoS One. 2024 May 29;19(5):e0302998. doi: 10.1371/journal.pone.0302998. eCollection 2024. PLoS One. 2024. PMID: 38809849 Free PMC article. Clinical Trial.
Protocol for the Brain Health Support Program Study of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP): A Prospective 12-Month Intervention Study.
Feldman HH, Belleville S, Nygaard HB, Montero-Odasso M, Durant J, Lupo JL, Revta C, Chan S, Cuesta M, Slack PJ, Winer S, Brewster PWH, Hofer SM, Lim A, Centen A, Jacobs DM, Anderson ND, Walker JD, Speechley MR, Zou GY, Chertkow H. Feldman HH, et al. Among authors: jacobs dm. J Prev Alzheimers Dis. 2023;10(4):875-885. doi: 10.14283/jpad.2023.65. J Prev Alzheimers Dis. 2023. PMID: 37874110 Free PMC article.
Overcoming Barriers to Latino Participation in Alzheimer's Disease Research.
Ramirez KA, Gigliotti C, Little EA, Peavy GM, Evans C, Paredes AM, Pacheco-Cole L, Zlatar ZZ, Jacobs DM, Gollan TH, González HM, Soria-Lopez JA, Huisa BN, Brewer JB, Galasko D, Salmon DP. Ramirez KA, et al. Among authors: jacobs dm. Int J Aging Hum Dev. 2024 Aug 16:914150241268259. doi: 10.1177/00914150241268259. Online ahead of print. Int J Aging Hum Dev. 2024. PMID: 39149977
Differences in prescribing patterns of opioid dependence drugs among patients with primary alcohol use problems and opioid use disorders within New York State by social determinant factors, 2005-2018.
Lu CH, Su HY, Falls Z, Jacobs DM, Zhang Q, Gibson W, Jette G, Paul D, Elkin PL, Leonard KE, Bednarczyk EM. Lu CH, et al. Among authors: jacobs dm. J Am Pharm Assoc (2003). 2024 Sep 27:102258. doi: 10.1016/j.japh.2024.102258. Online ahead of print. J Am Pharm Assoc (2003). 2024. PMID: 39343100
272 results